Osl asx

Morningstar Investor users sign in here.

Financial Times Close. Search the FT Search. Show more World link World. Show more US link US. Show more Companies link Companies. Show more Tech link Tech. Show more Markets link Markets.

Osl asx

Financial Times Close. Search the FT Search. Show more World link World. Show more US link US. Show more Companies link Companies. Show more Tech link Tech. Show more Markets link Markets. Show more Opinion link Opinion. Show more Personal Finance link Personal Finance. Actions Add to watchlist Add to portfolio Add an alert. Health Care Pharmaceuticals and Biotechnology. Price AUD 0. Use our equities screener to discover other potential opportunities. Add to Your Watchlists New watchlist. Add to Your Portfolio New portfolio.

Morningstar equity research methodology.

OncoSil Medical Limited. Is OSL undervalued compared to its fair value, analyst forecasts and its price relative to the market? For this estimate we use a Discounted Cash Flow model. This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors. What is the analyst month forecast and do we have any statistical confidence in the consensus price target? Analyst Forecast: Insufficient data to show price forecast. View Company Overview.

Key events shows relevant news articles on days with large price movements. Polynovo Ltd. PNV 4. Imugene Ltd. IMU 0. Mesoblast Ltd. MSB 7. Actinogen Medical Ltd. ACW 3.

Osl asx

Market data is provided and copyrighted by Thomson Reuters and Morningstar. Click for restrictions. All rights reserved. ASX shareholders. Our Board. Corporate governance.

Ihlas ev aletleri

He previously contributed substantially to the growth of two international healthcare marketing communication consultancies from start up to the largest practices in their sectors, as well as the leading oncology patient information and chemotherapy prescribing system. Morningstar Investment Conference for Financial Professionals. Dividend payments in the coming 90 days. We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. ASX shareholders. For Advisers. To access these valuable tools and see the full perspective, subscribe now. Roundup of ASX market movements. Your password should be characters Invalid password: this word has been flagged as unsuitable for use as a secure password. See more updates Recent updates. Morningstar Essentials. He trained in general internal medicine, medical oncology and radiation oncology and completed a Phd on DNA damage repair.

OncoSil Medical Ltd is an Australia-based medical device company seeking to advance radiation for cancer patients. The Company is focused on the development and commercialization of its lead product candidate, OncoSil localized radiation therapy, for the treatment of pancreatic and distal cholangiocarcinoma.

Is OSL undervalued compared to its fair value, analyst forecasts and its price relative to the market? All content on FT. Subscribers benefit from access to:. Necessary Necessary. Morningstar Investor. He has over publications in peer-reviewed scientific journals, including Lancet and Nature journals. Morningstar Investor users sign in here. You might already have an ASX account with another platform. We encourage our shareholders to attend and participate at our annual general meetings. Manager Spotlight. View Company Overview. In this role, Nicole oversees global strategic alignment to support the business growth through the overall development, implementation, maintenance, compliance, and execution of strategies ensuring that approaches are innovative, industry-leading, and meeting the needs of customers and the business from a Quality and Regulatory perspective. It does not store any personal data. Cancel Continue.